NeilAlanShneiderMDPhD

Neuromuscular Medicine

The Claire Tow Associate Professor of Motor Neuron Disorders and Director, The Eleanor and Lou Gehrig ALS Center at Columbia University

Request Appointment

Overview of Dr. Shneider

Dr. Neil Shneider is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 23 years. Dr. Shneider accepts several types of health insurance, listed below. He is one of 482 doctors at New York-Presbyterian Hospital and one of 212 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. He has more than 50 publications and over 500 citings.

Office
710 West 168th Street
New York, NY 10032
Book by Phone+1(918) 926-7622

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1995 - 1998
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1994 - 1995
Columbia University Vagelos College of Physicians and SurgeonsClass of 1994

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 1998 - 2025
MD State Medical License 2002 - 2009
DC State Medical License 2002 - 2004
MA State Medical License 1997 - 1998

Publications & Presentations

PubMed

1 citations
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis.
James D Berry, Sabrina Paganoni, Matthew B Harms, Neil Shneider, Jinsy Andrews
Muscle & Nerve. 2024-12-01
A cross-disease resource of living human microglia identifies disease-enriched subsets and tool compounds recapitulating microglial states.
John F Tuddenham, Mariko Taga, Verena Haage, Victoria S Marshe, Tina Roostaei
Nature Neuroscience. 2024-12-01
Body mass index is lower in asymptomaticexpansion carriers but not inpathogenic variant carriers compared to gene negatives.
Ikjae Lee, Mark A Garret, Joanne Wuu, Elizabeth A Harrington, James D Berry
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024-11-01

Press Mentions

Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)September 22nd, 2022
New Initiative to Develop Personalized Therapies for People with Rare Genetic Forms of ALSMay 10th, 2022
N-lorem Foundation and Columbia University Establish Silence ALS InitiativeMay 3rd, 2022
Join now to see all

Grant Support

FUS/TLS GAIN AND LOSS OF FUNCTION IN ALS: ANIMAL AND CELLULAR MODELS OF DISEASENational Institute of Neurological Disorders and Stroke2011–2016

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Access Choice PPO
Anthem Blue Access PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Health Care PPO Platinum
Coventry Missouri - HMO/POS
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
Great West PPO
HealthLink PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment